The association between hypovitaminosis D and metabolic syndrome: current understanding

References

• Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640–1645 (2009). •• Describes the most used definition of the metabolic syndrome.
   Google Scholar
• Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J. Am. Coll. Cardiol. 47(6), 1093–1100 (2006).
   Google Scholar
• Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 156(11), 1070–1077 (2002).
   Google Scholar
• Ninomiya JK, L’italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109(1), 42–46 (2004).
   Google Scholar
• Ju SY, Jeong HS, Kim Do H. Blood vitamin D status and metabolic syndrome in the general adult population: a doseresponse meta-analysis. J. Clin. Endocrinol. Metab. 99(3), 1053–1063 (2014).
   Google Scholar
• Rosen CJ, Adams JS, Bikle DD et al. The nonskeletal effects of vitamin D: an endocrine society scientific statement. Endocr. Rev. 33(3), 456–492 (2012).
   Google Scholar
• Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 61(Suppl. 3), S638–S645 (1995).
   Google Scholar
• Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87(4), S1080–S1086 (2008).
   Google Scholar
• Miñambres I, de Leiva A, Pérez A. [Hipovitaminosis D y síndrome metabólico]. Med. Clin. (Barc.) 143(12), 542–547 (2014).
   Google Scholar
• Holick MF. Vitamin D deficiency. N. Engl. J. Med. 357(3), 266–281 (2007). •• Review of hypovitaminosis D and its causes and treatment.
   Google Scholar
• Chen TC, Chimeh F, Lu Z et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch. Biochem. Biophys. 460(2), 213–217 (2007).
   Google Scholar
• Holick MF. McCollum Award Lecture, 1994: vitamin D – new horizons for the 21st century. Am. J. Clin. Nutr. 60(4), 619–630 (1994).
   Google Scholar
• Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320(15), 980–991 (1989).
   Google Scholar
• Bell NH. Vitamin D-endocrine system. J. Clin. Invest. 76(1), 1–6 (1985).
   Google Scholar
• Haussler MR, Mccain TA. Basic and clinical concepts related to vitamin D metabolism and action (first of two parts). N. Engl. J. Med. 297(18), 974–983 (1977).
   Google Scholar
• Holick MF. The use and interpretation of assays for vitamin D and its metabolites. J. Nutr. 120(Suppl. 11), 1464–1469 (1990).
   Google Scholar
• Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22(4), 477–501 (2001).
   Google Scholar
• Ross AC, Manson JE, Abrams SA et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96(1), 53–58 (2011). • Conflict between the institutes of medicine and the endocrine society concerning the definition of hypovitaminosis D.
   Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J. Clin. Endocrinol. Metab. 97(4), 1153–1158 (2012).
   Google Scholar
• Ganji V, Zhang X, Tangpricha V. Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J. Nutr. 142(3), 498–507 (2012).
   Google Scholar
• Yu S, Fang H, Han J et al. The high prevalence of hypovitaminosis D in China: a multicenter vitamin D status survey. Medicine (Baltimore) 94(8), e585 (2015).
   Google Scholar
• Arabi A, El Rassi R, El-Hajj Fuleihan G. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat. Rev. Endocrinol. 6(10), 550–561 (2010).
   Google Scholar
• Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B et al. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J. Bone Miner. Res. 24(5), 935–942 (2009).
   Google Scholar
• Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293(18), 2257–2264 (2005).
   Google Scholar
• Bischoff-Ferrari HA, Willett WC, Wong JB et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 169(6), 551–561 (2009).
   Google Scholar
• Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 291(16), 1999–2006 (2004).
   Google Scholar
• Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339, b3692 (2009).
   Google Scholar
• Bischoff-Ferrari HA. Relevance of vitamin D in muscle health. Rev. Endocr. Metab. Disord. 13(1), 71–77 (2012).
   Google Scholar
• Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9(3), 227–231 (1980).
   Google Scholar
• Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int. J. Epidemiol. 23(6), 1133–1136 (1994).
   Google Scholar
• Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res. 10(5A), 1307–1311 (1990).
   Google Scholar
• Gombart AF, Luong QT, Koeffler HP. Vitamin D compounds: activity against microbes and cancer. Anticancer Res. 26(4A), 2531–2542 (2006).
   Google Scholar
• Scragg R. Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood. Public Health Nutr. 14(9), 1515–1532 (2011).
   Google Scholar
• Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol. Aspects Med. 29(6), 361–368 (2008).
   Google Scholar
• Zittermann A, Prokop S. The role of vitamin D for cardiovascular disease and overall mortality. Adv. Exp. Med. Biol. 810, 106–119 (2014).
   Google Scholar
• Rejnmark L, Avenell A, Masud T et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J. Clin. Endocrinol. Metab. 97(8), 2670–2681 (2012).
   Google Scholar
• Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167(16), 1730–1737 (2007).
   Google Scholar
• Bjelakovic G, Gluud LL, Nikolova D et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 2(7), CD007470 (2011).
   Google Scholar
• Wang L, Song Y, Manson JE et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 5(6), 819–829 (2012).
   Google Scholar
• Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 94(4), 483–492 (2005).
   Google Scholar
• Fan C, Nieto FJ, Bautista LE, Fine JP. Vitamin D intake and cardiovascular mortality in the NHANES I epidemiological follow-up study cohort. J. Diet. Suppl. 9(2), 79–89 (2012).
   Google Scholar
• Parker J, Hashmi O, Dutton D et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65(3), 225–236 (2010).
   Google Scholar
• Schierbeck LL, Jensen TS, Bang U, Jensen G, Kober L, Jensen JE. Parathyroid hormone and vitamin D – markers for cardiovascular and all cause mortality in heart failure. Eur. J. Heart Fail. 13(6), 626–632 (2011).
   Google Scholar
• Wang TJ, Pencina MJ, Booth SL et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4), 503–511 (2008).
   Google Scholar
• Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 168(15), 1629–1637 (2008).
   Google Scholar
• Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168(11), 1174–1180 (2008).
   Google Scholar
• Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168(12), 1340–1349 (2008).
   Google Scholar
• Anderson JL, May HT, Horne BD et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106(7), 963–968 (2010).
   Google Scholar
• Ford ES, Zhao G, Tsai J, Li C. Vitamin D and all-cause mortality among adults in USA: findings from the National Health and Nutrition Examination Survey Linked Mortality Study. Int. J. Epidemiol. 40(4), 998–1005 (2011).
   Google Scholar
• Ford ES, Ajani UA, Mcguire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28(5), 1228–1230 (2005). • One of the first investigations to describe an association between hypovitaminosis D and metabolic syndrome.
   Google Scholar
• Maki KC, Fulgoni VL 3rd, Keast DR, Rains TM, Park KM, Rubin MR. Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. adults: National Health and Nutrition Examination Surveys 2003–2006. Metab. Syndr. Relat. Disord. 10(5), 363–372 (2012).
   Google Scholar
• Reis JP, Von Muhlen D, Miller ER, 3rd. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur. J. Endocrinol. 159(1), 41–48 (2008).
   Google Scholar
• Lee DM, Rutter MK, O’neill TW et al. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur. J. Endocrinol. 161(6), 947–954 (2009).
   Google Scholar
• Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57(2), 298–305 (2008).
   Google Scholar
• Kim MK, Il Kang M, Won Oh K et al. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin. Endocrinol. (Oxf.) 73(3), 330–338 (2010).
   Google Scholar
• Moy FM, Bulgiba A. High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia. BMC Public Health 11, 735 (2011).
   Google Scholar
• Minambres I, Sanchez-Hernandez J, Sanchez-Quesada JL, Rodriguez J, De Leiva A, Perez A. The association of hypovitaminosis D with the metabolic syndrome is independent of the degree of obesity. ISRN Endocrinol. 2012, 691803 (2012).
   Google Scholar
• Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, Type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc. Nutr. Soc. 72(1), 89–97 (2013).
   Google Scholar
• Wongwiwatthananukit S, Sansanayudh N, Phetkrajaysang N, Krittiyanunt S. Effects of vitamin D2 supplementation on insulin sensitivity and metabolic parameters in metabolic syndrome patients. J. Endocrinol. Invest. 36(8), 558–563 (2013).
   Google Scholar
• Kelishadi R, Salek S, Salek M, Hashemipour M, Movahedian M. Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. J. Pediatr. (Rio J.) 90(1), 28–34 (2014).
   Google Scholar
• Swapna N, Vamsi UM, Usha G, Padma T. Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension. Indian J. Hum. Genet. 17(3), 201–206 (2011).
   Google Scholar
• Vedralova M, Kotrbova-Kozak A, Zeleznikova V, Zoubkova H, Rychlik I, Cerna M. Polymorphisms in the vitamin D receptor gene and parathyroid hormone gene in the development and progression of diabetes mellitus and its chronic complications, diabetic nephropathy and nondiabetic renal disease. Kidney Blood Press. Res. 36(1), 1–9 (2012).
   Google Scholar
• Li L, Wu B, Liu JY, Yang LB. Vitamin D receptor gene polymorphisms and Type 2 diabetes: a meta-analysis. Arch. Med. Res. 44(3), 235–241 (2013).
   Google Scholar
• Wang G, Li Y, Li L et al. Association of the vitamin D binding protein polymorphisms with the risk of Type 2 diabetes mellitus: a meta-analysis. BMJ Open 4(11), e005617 (2014).
   Google Scholar
• Jia J, Shen C, Mao L, Yang K, Men C, Zhan Y. Vitamin D receptor genetic polymorphism is significantly associated with decreased risk of hypertension in a Chinese Han population. J. Clin. Hypertens. (Greenwich) 16(9), 634–639 (2014).
   Google Scholar
• Zhao Y, Liao S, He J et al. Association of vitamin D receptor gene polymorphisms with metabolic syndrome: a case-control design of population-based cross-sectional study in North China. Lipids Health Dis. 13, 129 (2014).
   Google Scholar
• Wang L, Ma J, Manson JE, Buring JE, Gaziano JM, Sesso HD. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur. J. Nutr. 52(7), 1771–1779 (2013).
   Google Scholar
• Vimaleswaran KS, Power C, Hypponen E. Interaction between vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D concentrations on metabolic and cardiovascular disease outcomes. Diabetes Metab. 40(5), 386–389 (2014).
   Google Scholar
• Leong A, Rehman W, Dastani Z et al. The causal effect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization study. PLoS Med. 11(10), e1001751 (2014).
   Google Scholar
• Afzal S, Brondum-Jacobsen P, Bojesen SE, Nordestgaard BG. Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2(4), 298–306 (2014).
   Google Scholar
• Vimaleswaran KS, Berry DJ, Lu C et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 10(2), e1001383 (2013).
   Google Scholar
• Vimaleswaran KS, Cavadino A, Berry DJ et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2(9), 719–729 (2014).
   Google Scholar
• Ybarra J, Sanchez-Hernandez J, Gich I et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes. Surg. 15(3), 330–335 (2005).
   Google Scholar
• Sanchez-Hernandez J, Ybarra J, Gich I et al. Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes. Surg. 15(10), 1389–1395 (2005).
   Google Scholar
• Snijder MB, Van Dam RM, Visser M et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J. Clin. Endocrinol. Metab. 90(7), 4119–4123 (2005).
   Google Scholar
• Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes. Rev. 16(4), 341–349 (2015).
   Google Scholar
• Cheng S, Massaro JM, Fox CS et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 59(1), 242–248 (2010).
   Google Scholar
• Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int. J. Obes. (Lond.) 36(3), 387–396 (2012).
   Google Scholar
• Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S. Vitamin D and its relationship with obesity and muscle. Int. J. Endocrinol. 2014, 841248 (2014).
   Google Scholar
• Tzotzas T, Papadopoulou FG, Tziomalos K et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J. Clin. Endocrinol. Metab. 95(9), 4251–4257 (2010).
   Google Scholar
• Lin E, Armstrong-Moore D, Liang Z et al. Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity 19(3), 588–594 (2011).
   Google Scholar
• Chandler PD, Wang L, Zhang X et al. Effect of vitamin D supplementation alone or with calcium on adiposity measures: a systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 73(9), 577–593 (2015). •• meta-analysis of the effect of vitamin D supplementation on bodyweight.
   Google Scholar
• Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. Br. J. Nutr. 108(11), 1915–1923 (2012).
   Google Scholar
• Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27(12), 2813–2818 (2004).
   Google Scholar
• Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of Type 2 diabetes: a prospective cohort study and metaanalysis. Clin. Chem. 59(2), 381–391 (2013).
   Google Scholar
• Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in Type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 92(6), 2017–2029 (2007).
   Google Scholar
• Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 48(7), 1247–1257 (2005).
   Google Scholar
• Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinol. Metab. Clin. North Am. 43(1), 205–232 (2014).
   Google Scholar
• Kayaniyil S, Vieth R, Retnakaran R et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for Type 2 diabetes. Diabetes Care 33(6), 1379–1381 (2010).
   Google Scholar
• Hypponen E. Vitamin D and increasing incidence of Type 1 diabetes-evidence for an association? Diabetes Obes. Metab. 12(9), 737–743 (2010).
   Google Scholar
• Maestro B, Campion J, Davila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr. J. 47(4), 383–391 (2000).
   Google Scholar
• Maestro B, Molero S, Bajo S, Davila N, Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem. Funct. 20(3), 227–232 (2002).
   Google Scholar
• Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30(4), 980–986 (2007).
   Google Scholar
• Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur. J. Nutr. 48(6), 349–354 (2009).
   Google Scholar
• Yiu YF, Yiu KH, Siu CW et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with Type 2 diabetes. Atherosclerosis 227(1), 140–146 (2013).
   Google Scholar
• Soric MM, Renner ET, Smith SR. Effect of daily vitamin D supplementation on HbA1c in patients with uncontrolled Type 2 diabetes mellitus: a pilot study. J. Diabetes 4(1), 104–105 (2012).
   Google Scholar
• Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 94(2), 486–494 (2011).
   Google Scholar
• Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 36(2), 260–266 (2013).
   Google Scholar
• Seida JC, Mitri J, Colmers IN et al. Clinical review: effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 99(10), 3551–3560 (2014).
   Google Scholar
• George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet. Med. 29(8), e142–e150 (2012). •• meta-analysis about the effect of vitamin D supplementation on type 2 diabetes.
   Google Scholar
• Ishida H, Seino Y, Tsuda K et al. Effects of streptozotocininduced diabetes on circulating levels of vitamin D metabolites. Acta Endocrinol. (Copenh.) 104(1), 96–102 (1983).
   Google Scholar
• Nyomba BL, Bouillon R, Lissens W, Van Baelen H, De Moor P. 1,25-Dihydroxyvitamin D and vitamin D-binding protein are both decreased in streptozotocin-diabetic rats. Endocrinology 116(6), 2483–2488 (1985).
   Google Scholar
• Nagasaka S, Murakami T, Uchikawa T, Ishikawa SE, Saito T. Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus. Endocr. J. 42(3), 377–383 (1995).
   Google Scholar
• Sayinalp S, Gedik O, Koray Z. Increasing serum osteocalcin after glycemic control in diabetic men. Calcif. Tissue Int. 57(6), 422–425 (1995).
   Google Scholar
• Minambres I, Sanchez-Quesada JL, Vinagre I et al. Hypovitaminosis D in Type 2 diabetes: relation with features of the metabolic syndrome and glycemic control. Endocr. Res. 40(3), 160–165 (2014).
   Google Scholar
• Lu L, Yu Z, Pan A et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32(7), 1278–1283 (2009).
   Google Scholar
• Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation 126(3), 270–277 (2012).
   Google Scholar
• Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog. Lipid Res. 50(4), 303–312 (2011). •• meta-analysis of the effect of vitamin D supplementation on lipids.
   Google Scholar
• Minambres I, Sanchez-Quesada JL, Sanchez-Hernandez J, Rodriguez J, De Leiva A, Perez A. Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment. Diabetol. Metab. Syndr. 6(1), 7 (2014).
   Google Scholar
• Grimes DS. Statins and vitamin D : editorial to: “increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?” by Bunyamin Yavuz et al. Cardiovasc. Drugs Ther. 23(4), 261–262 (2009).
   Google Scholar
• Schnatz PF, Jiang X, Vila-Wright S et al. Calcium/ vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women’s Health Initiative calcium/vitamin D randomized trial. Menopause 21(8), 823–833 (2014).
   Google Scholar
• Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis. 11, 42 (2012).
   Google Scholar
• Qin XF, Zhao LS, Chen WR, Yin Da W, Wang H. Effects of vitamin D on plasma lipid profiles in statin-treated patients with hypercholesterolemia: a randomized placebo-controlled trial. Clin. Nutr. 34(2), 201–206 (2015).
   Google Scholar
• Elamin MB, Abu Elnour NO, Elamin KB et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96(7), 1931–1942 (2011).
   Google Scholar
• Pittas AG, Chung M, Trikalinos T et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 152(5), 307–314 (2010).
   Google Scholar
• Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J. Hypertens. 29(4), 636–645 (2011).
   Google Scholar
• Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur. J. Epidemiol. 28(3), 205–221 (2013).
   Google Scholar
• Carbone F, Mach F, Vuilleumier N, Montecucco F. Potential pathophysiological role for the vitamin D deficiency in essential hypertension. World J. Cardiol. 6(5), 260–276 (2014).
   Google Scholar
• Brinton GS, Jubiz W, Lagerquist LD. Hypertension in primary hyperparathyroidism: the role of the renin–angiotensin system. J. Clin. Endocrinol. Metab. 41(06), 1025–1029 (1975).
   Google Scholar
• Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 27(10), 1948–1954 (2009).
   Google Scholar
• Kunutsor SK, Burgess S, Munroe PB, Khan H. Vitamin D and high blood pressure: causal association or epiphenomenon? Eur. J. Epidemiol. 29(1), 1–14 (2014).
   Google Scholar
• Witham MD, Price RJ, Struthers AD et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern. Med. 173(18), 1672–1679 (2013).
   Google Scholar
• Arora P, Song Y, Dusek J et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation 131(3), 254–262 (2015).
   Google Scholar
• Pilz S, Gaksch M, Kienreich K et al. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension 65(6), 1195–1201 (2015).
   Google Scholar
• Scragg R, Slow S, Stewart AW et al. Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial. Hypertension 64(4), 725–730 (2014).
   Google Scholar
• Beveridge LA, Struthers AD, Khan F et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern. Med. 175(5), 745–754 (2015). • Analyses the effect of vitamin supplementation on hypertension.
   Google Scholar
• Manson JE, Bassuk SS, Lee IM et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials 33(1), 159–171 (2012).
   Google Scholar